Abstract
A link between leptin resistance, obesity, and salt sensitivity has been suggested. SHHF/Mcc-fa cp rats (SHHF) were used to study the effect of gene dosage of a null mutation of the leptin receptor (cp) on salt sensitivity and response to a combined endothelin A and B receptor antagonist (bosentan). Obese (cp/cp), heterozygous (+/cp), and homozygous lean (+/+) male SHHF were fed a low salt diet (0.3% NaCl) for 7 days, followed by a high salt diet (8.0% NaCl) for 7 days. There were no significant differences in systolic blood pressure between genotypes on low salt. In response to high salt, cp/cp had significantly greater systolic pressure than +/cp and +/+. On high salt diet, cp/cp showed a significant increase in 24 h urinary endothelin excretion and increased renal expression of preproendothelin mRNA. There was no effect of high salt diet on renal excretion of nitric oxide (NOx) or on gene expression of endothelial, neuronal, or cytokine-induced nitric oxide synthase isoforms (eNOS, nNOS, iNOS, respectively). Treatment with bosentan prevented the high salt-induced increment in systolic blood pressure in cp/cp. This was associated with a doubling of renal NOx excretion, but without changes in eNOS, nNOS, or iNOS expression. Endothelin receptor antagonism did not normalize systolic pressure in any of the genotypes. Our studies indicate that obesity secondary to leptin resistance (cp/cp) results in increased salt sensitivity that is mediated by endothelin in the SHHF rat.
Similar content being viewed by others
References
Hall JE, Hildebrandt DA, Kuo J: Obesity hypertension: Role of leptin and sympathetic nervous system. Am J Hypertens 14: 103S-115S, 2001
Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension 31: 409-414, 1998
Haynes WG, Morgan DA, Walsh SA, Sivitz WI, Mark AL: Cardiovascular consequences of obesity: Role of leptin. Clin Exp Pharmacol Physiol 25: 65-69, 1998
Hall JE: Pathophysiology of obesity hypertension. Curr Hypertens Rep 2: 139-147, 2000
Thakur V, Richards R, Reisin E: Obesity, hypertension, and the heart. Am J Med Sci 321: 242-248, 2001
Fujiwara K, Hayashi K, Matsuda H, Kubota E, Honda M, Ozawa Y, Saruta T: Altered pressure natriuresis in obese Zucker rats. Hypertension 33: 1470-1475, 1999
Carlson SH, Shelton J, White CR, Wyss JM: Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension 35: 403-408, 2000
Suzuki H, Ikenaga H, Hayashida T, Otsuka K, Kanno Y, Ohno Y, Ikeda H, Saruta T: Sodium balance and hypertension in obese and fatty rats. Kid Int 49(suppl 55): S150-S153, 1996
Jackson EK, Li P: Human leptin has natriuretic activity in the rat. Am J Physiol 272: F333-F338, 1997
Villarreal D, Reams G, Freeman RH, Taraben A: Renal effects of leptin in normotensive, hypertensive, and obese rats. Am J Physiol 275: R2056-R2060, 1998
McCune SA, Jenkins JE, Stills HF, Park S, Radin MJ, Jurin RR, Hamlin RE: Renal and heart function in the SHHF/Mcc-cp rat. In: E. Shafrir (ed). Frontiers in Diabetes Research. Lessons from Animal Diabetes III. Smith Gordon, Inc., London, 1990, pp 397-401
Ishizuka T, Ernsberger P, Liu S, Bedol D, Lehman TM, Koletsky RJ, Friedman JE: Phenotypic consequences of a nonsense mutation in the leptin receptor gene (fak) in obese spontaneously hypertensive Koletsky rats (SHROB). J Nutr 128: 2299-2306, 1998
McCune SA, Radin MJ, Jenkins JE, Chu Y, Park S, Peterson RG: SHHF/Mcc-facp rat model: Effects of gender and genotype on age of expression of metabolic complications and congestive heart failure and on response to drug therapy. In: E. Shafrir (ed.). Lessons from Animal Diabetes V. Smith-Gorden, London, 1995, pp 255-270
Sharkey LC, Holycross BJ, McCune SA, Radin MJ: Obese female SHHF/Mcc-fa cp rats resist antihypertensive effects of renin-angiotensin system inhibition. Clin Exp Hypertens 23: 227-239, 2001
Takaya K, Ogawa Y, Hiraoka J, Hosoda K, Yamori Y, Nakao K, Koletsky RJ: Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nature Gen 14: 130-131, 1996
Lepailleur-Enouf D, Egidy F, Philippe M, Louedec L, Henry J-P, Mulder P, Michea J-B: Pulmonary endothelinergic system in experimental congestive heart failure. Cardiovasc Res 49: 330-339, 2001
Mattson DL, Wu F: Nitric oxide synthase activity and isoforms in rat renal vasculature. Hypertension 35: 337-341, 2000
Goettsch W, Lattmann T, Amann K, Szibor M, Morawietz H, Münter K, Müller S, Shaw S, Barton M: Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: Implications for atherosclerosis. Biochem Biophys Res Commun 280: 980-913, 2001
Kassab S, Miller MT, Novak J, Reckelhoff J, Clower B, Granger JP: Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertension 31: 397-402, 1998
Rothermund L, Luckert S, Kobmehl P, Paul M, Kreutz R: Renal endothelin ETA/ETB receptor imbalance differentiates salt-sensitive from salt-resistant spontaneous hypertension. Hypertension 37: 275-280, 2001
Lariviere R, Day R, Schiffrin EL: Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 21: 916-920, 1993
Tan DY, Meng S, Manning RD Jr: Role of neuronal nitric oxide synthase in Dahl salt-sensitive hypertension. Hypertension 33: 456-461, 1999
Tan DY, Cason GW, Manning RD Jr: Mechanisms of salt-sensitive hypertension: Role of inducible nitric oxide synthase. Am J Physiol 279: R2297-R2303, 2000
Barton M, Vos I, Shaw S, Boer P, D'Uscio LV, Grone HJ, Rabelink TJ, Lattmann T, Moreau P, Luscher TF: Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: Mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis. J Am Soc Nephrol 11: 835-845, 2000
Ni Z, Oveisi F, Vaziri ND: Nitric oxide synthase isotype expression in salt-sensitive and salt-resistant Dahl rats. Hypertension 34: 552-557, 1999
Kuo JJ, Jones OB, Hall JE: Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension 37: 670-676, 2001
Houseknecht LK, Portocarrero CP: Leptin and its receptors: Regulators of whole-body energy homeostasis. Dom An Endocrinol 15: 457-475, 1998
Heskha JT, Jones PJH: A role for dietary fat in leptin receptor, OB-Rb, function. Life Sci 69: 987-1003, 2001
Schiffrin EL: Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 14: 83S-89S, 2001
Fortepiani LA, Janvier JJ, Ortiz MC, Atucha MN, Garcia-Estan J: Effect of endothelin blockade on pressure natriuresis in nitric oxide-deficient hypertensive rats. J Hypertens 17: 287-291, 1999
Kotelevtsev Y, Webb DJ: Endothelin as a natriuretic hormone: The case for a paracrine action mediated by nitric oxide. Cardiovasc Res 51: 481-488, 2001
Walker AB, Dores J, Buckingham RE, Savage MW, Williams G: Impaired insulin-induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker rats. Clin Sci 93: 235-241, 1997
McCune SA, Shiry LJ, Radin MJ, Holycross BJ, Loeffler B-M, Lindpainter K: Bosentan slows progression of heart failure in male SHHF rats. J Mol Cell Cardiol 32: A68, 2000
Holycross BJ, Summers BL, Dunn RB, McCune SA: Plasma renin activity in heart failure prone rats (SHHF/Mcc-facp). Am J Physiol 273: H228-H233, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Radin, M.J., Holycross, B.J., Hoepf, T.M. et al. Increased salt sensitivity secondary to leptin resistance in SHHF rats is mediated by endothelin. Mol Cell Biochem 242, 57–63 (2003). https://doi.org/10.1023/A:1021181527060
Issue Date:
DOI: https://doi.org/10.1023/A:1021181527060